Welcome to issue 73 of Pharmafile! This edition covers topics including respiratory research, oncology, and pain management

Chelsea Harbour Hotel: PharmaTimes Awards

This edition covers topics such as oncology, respiratory diseases, pain management and rare diseases

Paul O'Donohoe explores the changing landscape of the healthcare industry and the gradual transformation to a more digital world

PMGroup Webinars

Pharmafile speaks to Enara Bio: Enara Bio tell Pharmafile about the unmet patient needs in oncology, and how these can be tackled by novel therapies, as well as considering the future of immunotherapy

QIC Dermatology: Quality in Care Programme

The UK has seen many innovations in the healthcare sphere, many have which have been in oncology, but what are the next steps in this ever-evolving field?

How can precision medicine and personalised treatments improve healthcare in Europe and worldwide?

Precision medicine and targetted solutions can be utilised to treat cancer, but how can this develop in the future?

How can the benefits of immunotherapy be maximised for each patient?

Novartis UK tells Pharmafile how COVID-19 impacted patient access to oncology treatments, and how the pharma industry can support the NHS

Pharmafile speaks to Open Orphan: Open Orphan tells Pharmafile about the respiratory disease landscape, as well as how human challenge trials may further understanding of the area

Aptar Pharma discuss how PMDIs continue to change the landscape of asthma and COPD treatment

Aptar Pharma: Working daily to improve the health of our patients and our planet

Galecto tells Pharmafile about the benefits of inhaled technology to treat idiopathic pulmonary fibrosis

RedX share their thoughts about the current and future treatments for idiopathic pulmonary fibrosis

Pharmatimes: Clinical Researcher of the Year - The Americas!

Pharmafile speaks to Sapphire Clinics: Sapphire Clinics discuss the benefits of medical cannabis for pain management and how this has changed in the last decade

Pain management is key for both patient and HCP, but how can compounding medication aid in treatment?

Samedan Ltd: Fast, Effective Insight

Pharmafile speaks to Futura for their insights into the effective delivery of drugs for pain management and alternative technologies

Communique Awards 2022: For Medical Affairs and Healthcare Communications

Many advancements have been made within the rare disease field, including gene editing and viral delivery strategies

Takeda tells Pharmafile about the role of combination treatments in rare diseases, and strategies to make them more accessible

EVENTS SUMMER 2022

Innovations in Pharmaceutical Technology: Samedan Ltd

FlyPharma Conference Europe 2022: 20-21 September 2022